Skip to main content
STRATEC SE logo

STRATEC SE — Investor Relations & Filings

Ticker · SBS ISIN · DE000STRA555 LEI · 529900ZZJWANAFSPGV30 F Manufacturing
Open in API
Filings indexed 828 across all filing types
Latest filing 2009-12-11 Declaration of Voting R…
Country DE Germany
Listing F SBS

About STRATEC SE

https://www.stratec.com/home

STRATEC SE is a global partner specializing in the design and manufacturing of fully automated solutions for OEM partners in the clinical diagnostics and life sciences industries. The company provides a comprehensive, integrated portfolio covering the entire value chain, from development and design to production and quality assurance. Its core offerings include fully automated analyzer systems (instrumentation), custom software and digital IoT solutions, and smart polymer-based consumables. Leveraging decades of experience and a broad technology base, STRATEC delivers tailored, high-quality systems that meet stringent regulatory standards, enabling its partners to bring advanced diagnostic and life science products to market.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2009
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states in the title and header that it is a 'Voting Rights Announcement' and references Article 21, Section 1 of the WpHG (German Securities Trading Act), which governs the notification of changes in major shareholdings/voting rights. The content details multiple instances where a shareholder's voting rights crossed above or fell below the 5% threshold. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or related notifications like voting rights changes.
2009-12-11 English
STRATEC Biomedical Systems AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is very short (1273 characters) and announces the 'Total Voting Rights' as of November 30, 2009. It explicitly states the number of voting rights (11,445,736). This type of announcement, which reports on the total number of shares carrying voting rights, is a specific regulatory disclosure. While it relates to shareholder structure, it is not a general AGM result (DVA) or a director's dealing (DIRS). It is a specific regulatory notification regarding capital structure/voting rights disclosure, which fits best under the general 'Regulatory Filings' (RNS) category as a specific disclosure that doesn't match the other specialized codes like DIV, SHA, or DVA, or it could be interpreted as a specific type of capital/share structure update. Given the options, 'RNS' (Regulatory Filings) is the most appropriate fallback for a specific, non-standard regulatory disclosure about total voting rights, as it is not a declaration of voting results (DVA) but a statement of the total count.
2009-11-30 English
Declaration of Voting Results & Voting Rights Announcements 2009
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states in the title and header that it is a 'Voting Rights Announcement' and references German Securities Trading Act (WpHG) sections related to voting rights notifications (Article 21, Section 1). It details multiple instances where major shareholders (Fidelity Funds SICAV, FIL Limited, etc.) crossed the 3% threshold of voting rights in STRATEC Biomedical Systems AG. This directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2009-11-02 English
STRATEC Biomedical Systems AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is very short (1213 characters) and explicitly states it is a 'Total Voting Rights announcement' according to Article 26a of the WpHG. This type of announcement, detailing the total number of voting rights outstanding as of a specific date (October 30, 2009), directly relates to shareholder voting structure and rights, but it is not the result of a vote (DVA) nor is it a proxy solicitation (PSI). It is a specific regulatory disclosure regarding the capital structure relevant to voting. Given the options, this fits best under 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the total number of rights available for voting, which is a prerequisite for any vote outcome. It is a specific regulatory filing, but DVA is the most precise fit among the provided codes for a total voting rights disclosure.
2009-10-30 English
DGAP-DD: STRATEC Biomedical Systems AG english
Director's Dealing Classification · 1% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction (Sale of 8600 shares) by the spouse of a person performing managerial responsibilities (Marcella Wolfinger, spouse of a Member of a managing body) in STRATEC Biomedical Systems AG. This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2009-10-30 English
DGAP-DD: STRATEC Biomedical Systems AG english
Director's Dealing Classification · 1% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction (Sale of 6400 shares) by the spouse of a person holding a managerial position ('Member of a managing body'). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2009-10-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.